The effect of combination of valproic acid and anti-tumor drug on pancreatic and biliary cancer
Phase 1
- Conditions
- unresectable or reccurrent pancreatic cancer and biliary cancer (20 patients)
- Registration Number
- JPRN-UMIN000004525
- Lead Sponsor
- Department of surgery, Tokushima university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1) The patients have severe organ disorder. (2) The patients have more than 2.5 times of AST or ALT. (3) The patients have more than 2mg/dl of Total-Bilirubin. (4) The patients have more than 5mg/dl of Creatinin. (5) The patients have less than 90% of SaO2. (6) The patients have severe organ complication. (7) The patiens have allergy. (8) The patients have agressive duplication cancer. (9) The patients is considered unaddaptive.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method tumor marker and tumor size
- Secondary Outcome Measures
Name Time Method